Pembrolizumab as adjuvant therapy in non-small-cell lung cancer

Saved in:
Bibliographic Details
Published in:The lancet oncology 2022-12, Vol.23 (12), p.e527-e527
Main Author: Uprety, Dipesh
Format: Article
Language:English
Subjects:
Adjuvant therapy
Antibodies, Monoclonal, Humanized - adverse effects
Cancer therapies
Carcinoma, Non-Small-Cell Lung - drug therapy
Chemotherapy
Combined Modality Therapy
Humans
Lung cancer
Lung Neoplasms - drug therapy
Metastasis
Mutation
Non-small cell lung carcinoma
Pembrolizumab
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1470-2045
1474-5488
DOI:10.1016/S1470-2045(22)00636-2